FDA Approves Neupro Patch for Treatment of Early Parkinson's Disease |

« FDA Announces Results of Investigation Into Illegal Promotion of OxyContin | Main | FDA Approvals - Oculus Innovative Sciences Microcyn(R) Technology Presented in Poster at European »

FDA Approves Neupro Patch for Treatment of Early Parkinson's Disease

FDA Approves Neupro Patch for Treatment of Early Parkinson's Disease
Rotigotine is a drug not previously approved in the United States. Neupro is the first transdermal patch approved for the treatment of symptoms of Parkinson's disease.

Additional information in: Breaking News , FDA Recalls

FDA News Search

Get Legal Help

Breaking FDA Recalls

Breaking FDA Approvals

Health Tip

It’s a little known fact that coffee benefits your health in a variety of important ways .

Food & Drug Categories

FDA News Archive

Subscribe to this site's RSS feed
FDA Resources

FDA News Site Map
FDA Online Resources
FDA Related Resources